Literature DB >> 6782861

Long-term treatment of systemic mastocytosis with histamine H2 receptor antagonists.

G J Johnson, S E Silvis, B Roitman, M Blumenthal, H S Gilbert.   

Abstract

A patient with systemic mastocytosis, accompanied by gastric hypersecretion and duodenal ulcer, was treated with metiamide followed by daily cimetidine for 44 months. Treatment with cimetidine resulted in healing of the ulcer, without recurrence and marked amelioration of the cutaneous symptoms of mastocytosis. Complete suppression of basal gastric hypersecretion was documented after 33 months of treatment and cimetidine and Vitamin B12 absorption remained normal. Cimetidine reduced the patient's cutaneous response to intradermal histamine without affecting leucocyte histamine release. No cimetidine toxicity was observed. These results indicate that effective long-term control of histamine-induced gastric hypersecretion can be achieved with cimetidine. They suggest that some of the cutaneous symptoms of mastocytosis are mediated via histamine H2 receptors in the skin.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6782861

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  6 in total

1.  Case report 369: Systemic mastocytosis.

Authors:  J C Rodenberg; K K Maegaard; H Svanholm
Journal:  Skeletal Radiol       Date:  1986       Impact factor: 2.199

Review 2.  Diagnosis and treatment of cutaneous mastocytosis in children: practical recommendations.

Authors:  Mariana Castells; Dean D Metcalfe; Luis Escribano
Journal:  Am J Clin Dermatol       Date:  2011-08-01       Impact factor: 7.403

3.  Systemic mastocytosis: case report and literature review.

Authors:  A H Peterson
Journal:  J Natl Med Assoc       Date:  1984-05       Impact factor: 1.798

4.  Phototherapy of urticaria pigmentosa: clinical response and changes of cutaneous reactivity, histamine and chemotactic leukotrienes.

Authors:  B M Czarnetzki; T Rosenbach; G Kolde; P J Frosch
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

Review 5.  Mastocytosis: update on pharmacotherapy and future directions.

Authors:  Juan Carlos Cardet; Cem Akin; Min Jung Lee
Journal:  Expert Opin Pharmacother       Date:  2013-10       Impact factor: 3.889

Review 6.  Telangiectasia macularis eruptiva perstans: more than skin deep.

Authors:  Casey E Watkins; Winston B Bokor; Stuart Leicht; George Youngberg; Guha Krishnaswamy
Journal:  Dermatol Reports       Date:  2011-07-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.